Stay updated on Cyclophosphamide+Pembrolizumab in Metastatic TNBC Clinical Trial
Sign up to get notified when there's something new on the Cyclophosphamide+Pembrolizumab in Metastatic TNBC Clinical Trial page.

Latest updates to the Cyclophosphamide+Pembrolizumab in Metastatic TNBC Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedAdded a Locations section listing District of Columbia, North Carolina, and Pennsylvania sites and updated to Revision: v3.3.3. Removed the previous standalone District of Columbia, North Carolina, and Pennsylvania location entries.SummaryDifference0.4%

- Check22 days agoNo Change Detected
- Check36 days agoChange Detected- Revision updated from v3.3.1 to v3.3.2. The update does not modify study details, eligibility criteria, or reported results.SummaryDifference0.1%

- Check43 days agoChange DetectedThe site revision updated from v3.2.0 to v3.3.1, a metadata change that does not affect study details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check51 days agoChange DetectedA notice about a lapse in government funding and NIH operating status was removed from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check65 days agoChange DetectedNo significant additions or deletions were detected on the page.SummaryDifference0.4%

- Check93 days agoChange DetectedUpdate adds a government-funding status notice and NIH Clinical Center operating details with a v3.2.0 revision, while removing the old v3.1.0 tag.SummaryDifference3%

Stay in the know with updates to Cyclophosphamide+Pembrolizumab in Metastatic TNBC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cyclophosphamide+Pembrolizumab in Metastatic TNBC Clinical Trial page.